Trial · NCT05919082
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Physician's Global Assessment of Disease Severity (PGA) Score of 0 (Clear) or 1 (Almost Clear) at Day 29, With at Least a 2-point Reduction From Baseline | LEO 90100 | 50.0 | 95% Confidence Interval 44.36 to 55.64 | Percentage of Participants | |
| Percentage of Participants With Physician's Global Assessment of Disease Severity (PGA) Score of 0 (Clear) or 1 (Almost Clear) at Day 29, With at Least a 2-point Reduction From Baseline | Daivobet® Ointment | 42.4 | 95% Confidence Interval 36.81 to 47.96 | Percentage of Participants | |
| Percentage of Participants With Decrease in Modified Psoriasis Area and Severity Index of at Least 75% (mPASI-75) From Baseline to Day 29 | LEO 90100 | 63.6 | 95% Confidence Interval 58.15 to 69.00 | Percentage of Participants | |
| Percentage of Participants With Decrease in Modified Psoriasis Area and Severity Index of at Least 75% (mPASI-75) From Baseline to Day 29 | Daivobet® Ointment | 53.6 | 95% Confidence Interval 48.02 to 59.27 | Percentage of Participants | |
| Percentage of Participants With Decrease in mPASI of at Least 90% (mPASI-90) From Baseline to Day 29 | LEO 90100 | 33.1 | 95% Confidence Interval 27.80 to 38.42 | Percentage of Participants | |
| Percentage of Participants With Decrease in mPASI of at Least 90% (mPASI-90) From Baseline to Day 29 | Daivobet® Ointment | 24.5 | 95% Confidence Interval 19.65 to 29.35 | Percentage of Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | LEO 90100 | Any TEAE | 77 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Daivobet Ointment | Any TEAE | 68 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | LEO 90100 | Leading to Deaths | 0 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Daivobet Ointment | Leading to Deaths | 0 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | LEO 90100 | Serious | 4 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Daivobet Ointment | Serious | 0 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | LEO 90100 | Non-Serious | 75 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Daivobet Ointment | Non-Serious | 68 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | LEO 90100 | Leading to Permanent Discontinuation from investigational medicinal product (IMP) | 3 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Daivobet Ointment | Leading to Permanent Discontinuation from investigational medicinal product (IMP) | 0 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | LEO 90100 | Leading to Withdrawals from the Trial | 3 | Participants | |
| Number of Participants With Treatment-emergent Adverse Events (TEAEs) | Daivobet Ointment | Leading to Withdrawals from the Trial | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05919082/results